↓ Skip to main content

Blockage of transdifferentiation from fibroblast to myofibroblast in experimental ovarian cancer models

Overview of attention for article published in Molecular Cancer, September 2009
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Blockage of transdifferentiation from fibroblast to myofibroblast in experimental ovarian cancer models
Published in
Molecular Cancer, September 2009
DOI 10.1186/1476-4598-8-78
Pubmed ID
Authors

Qin Yao, Xun Qu, Qifeng Yang, David A Good, Shuzhen Dai, Beihua Kong, Ming Q Wei

Abstract

Tumour stromal myofibroblasts can promote tumour invasion. As these cells are genetically more stable than cancer cells, there has been enormous interest in developing targeted molecular therapies against them. Chloride intracellular channel 4 (CLIC4) and reactive oxygen species (ROS) have been linked with promoting stromal cell transdifferentiation in various cancers, but little is known of their roles in ovarian cancer. In this study, we examined the functional roles that both CLIC4 and ROS play in the process of ovarian cancer cell-stimulated or TGF-beta1 induced fibroblast-to-myofibroblast transdifferentiation. We also examine whether it is possible to reverse such a process, with the aim of developing novel therapies against ovarian cancer by targeting activated transdifferentiated myofibroblasts.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
China 1 3%
Unknown 28 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 20%
Student > Ph. D. Student 5 17%
Professor 3 10%
Student > Master 3 10%
Student > Bachelor 2 7%
Other 8 27%
Unknown 3 10%
Readers by discipline Count As %
Medicine and Dentistry 8 27%
Agricultural and Biological Sciences 7 23%
Biochemistry, Genetics and Molecular Biology 5 17%
Nursing and Health Professions 1 3%
Physics and Astronomy 1 3%
Other 4 13%
Unknown 4 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 January 2015.
All research outputs
#18,388,295
of 22,776,824 outputs
Outputs from Molecular Cancer
#1,288
of 1,719 outputs
Outputs of similar age
#85,409
of 93,601 outputs
Outputs of similar age from Molecular Cancer
#7
of 9 outputs
Altmetric has tracked 22,776,824 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,719 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 93,601 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 4th percentile – i.e., 4% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.